T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Fastenal
FAST
$58.9B
| $160M | 0.02% |
3,997,993
-188,360
| -4% | -$7.93M |
|
527
BILL Holdings
BILL
$5.11B
| $160M | 0.02% |
2,930,803
-166,777
| -5% | -$8.57M |
|
528
Duke Energy
DUK
$97.1B
| $160M | 0.02% |
1,362,071
-2,801
| -0.2% | -$342K |
|
529
United Airlines
UAL
$41B
| $159M | 0.02% |
1,419,796
-12,722
| -0.9% | -$1.29M |
|
530
Itaú Unibanco
ITUB
$80.9B
| $158M | 0.02% |
22,069,750
-6,545,649
| -23% | -$46.6M |
|
531
Carrier Global
CARR
$52.2B
| $157M | 0.02% |
2,972,610
+232,373
| +8% | +$12.9M |
|
532
IQVIA
IQV
$39.8B
| $157M | 0.02% |
696,576
+1,639
| +0.2% | +$357K |
|
533
GitLab
GTLB
$7.32B
| $156M | 0.02% |
4,156,865
-424,041
| -9% | -$18.4M |
|
534
AppFolio
APPF
$7.22B
| $156M | 0.02% |
669,317
+98,230
| +17% | +$23.3M |
|
535
Floor & Decor
FND
$6.27B
| $154M | 0.02% |
2,528,058
-2,896,796
| -53% | -$188M |
|
|
SLNO
536
DELISTED
Soleno Therapeutics
SLNO
| $154M | 0.02% |
3,318,698
-584,208
| -15% | -$32M |
|
537
PNC Financial Services
PNC
$102B
| $153M | 0.02% |
735,385
+1,124
| +0.2% | +$217K |
|
538
Viking Holdings
VIK
$47.3B
| $153M | 0.02% |
2,137,005
-109,460
| -5% | -$6.98M |
|
539
Coinbase
COIN
$40.6B
| $152M | 0.02% |
671,601
-69,126
| -9% | -$20.6M |
|
540
Acuity Brands
AYI
$10.8B
| $151M | 0.02% |
420,357
+117,153
| +39% | +$42.3M |
|
541
iShares Russell 1000 Growth ETF
IWF
$129B
| $151M | 0.02% |
1,275,360
-1,916,720
| -60% | -$227M |
|
542
Royal Gold
RGLD
$19.1B
| $151M | 0.02% |
678,782
+14,929
| +2% | +$2.96M |
|
543
DuPont de Nemours
DD
$19.5B
| $150M | 0.02% |
1,246,146
-2,582,486
| -67% | -$291M |
|
544
Starbucks
SBUX
$124B
| $150M | 0.02% |
1,780,712
-6,556
| -0.4% | -$553K |
|
545
NRG Energy
NRG
$25.2B
| $150M | 0.02% |
941,102
-65,828
| -7% | -$10.9M |
|
546
Lockheed Martin
LMT
$138B
| $149M | 0.02% |
307,920
-10,570
| -3% | -$5.06M |
|
547
Expro Ltd
XPRO
$2.1B
| $147M | 0.02% |
11,030,884
+1,878,245
| +21% | +$25.3M |
|
548
Arthur J. Gallagher & Co
AJG
$65B
| $147M | 0.02% |
567,739
+171,278
| +43% | +$45.3M |
|
549
GE HealthCare
GEHC
$33.3B
| $145M | 0.02% |
1,769,376
-290,304
| -14% | -$22.6M |
|
550
NXP Semiconductors
NXPI
$58.5B
| $145M | 0.02% |
666,053
-2,139,128
| -76% | -$459M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.